<ARTICLE> 5
<LEGEND> Regeneron Pharmaceuticals, Inc.
         March 31, 1999 Form 10Q
         (in thousands except per share data)
</LEGEND>
<MULTIPLIER> 1000
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                          21,777
<SECURITIES>                                    82,794
<RECEIVABLES>                                    6,895
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                76,189
<PP&E>                                          61,578
<DEPRECIATION>                                  27,339
<TOTAL-ASSETS>                                 149,329
<CURRENT-LIABILITIES>                            9,859
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            28
<OTHER-SE>                                     123,408
<TOTAL-LIABILITY-AND-EQUITY>                   149,329
<SALES>                                              0
<TOTAL-REVENUES>                                 6,918
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                15,759
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  89
<INCOME-PRETAX>                                 (8,930)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (8,930)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (8,930)
<EPS-PRIMARY>                                     (.29)
<EPS-DILUTED>                                     (.29)